These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 9561021)
1. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage]. Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021 [TBL] [Abstract][Full Text] [Related]
2. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae. Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482 [TBL] [Abstract][Full Text] [Related]
3. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. McKinnon PS; Paladino JA; Schentag JJ Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
7. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease]. Targowski T; Jahnz-Rózyk K Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344 [TBL] [Abstract][Full Text] [Related]
8. Bronchial hyperresponsiveness and bacterial respiratory infections. Cazzola M; Matera MG; Rossi F Clin Ther; 1991; 13(1):157-71. PubMed ID: 1709390 [TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083 [TBL] [Abstract][Full Text] [Related]
10. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Anon JB Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103 [TBL] [Abstract][Full Text] [Related]
11. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections]. Elies W Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections. Gentry LO; Rodriguez-Gomez G; Pien F; Cubeddu L; Holley HP; Buaron K; Giguere G; Collins JJ Am J Ther; 1996 Mar; 3(3):212-218. PubMed ID: 11862252 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434 [TBL] [Abstract][Full Text] [Related]
14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
15. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid. Brook I; Foote PA; Hausfeld JN Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017 [TBL] [Abstract][Full Text] [Related]
17. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study. Alamoudi OS Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464 [TBL] [Abstract][Full Text] [Related]
18. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Leibovitz E; Greenberg D; Piglansky L; Raiz S; Porat N; Press J; Leiberman A; Dagan R Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580 [TBL] [Abstract][Full Text] [Related]
19. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030 [TBL] [Abstract][Full Text] [Related]
20. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers. Pasqua F; Biscione G; Crigna G; Cazzola M Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]